Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-026397
Filing Date
2017-05-11
Accepted
2017-05-11 14:32:36
Documents
1
Period of Report
2017-05-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v466674_4.html 4  
1 OWNERSHIP DOCUMENT v466674_4.xml 4 4399
  Complete submission text file 0001144204-17-026397.txt   5999
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CONOR MEDSYSTEMS, INC. 1003 HAMILTON COURT MENLO PARK CA 94025
Business Address
Musket David B (Reporting) CIK: 0001310611 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 17833764